🐦🔥nemo™🐦⬛ 🇺🇦🍉#reminder 💊🕵️♂️ Investigative Europe uncovers the hidden world of secret drug price negotiations in Europe, revealing how patients pay the price for opaque deals and unequal access to life-saving medicines. Transparency is urgently needed! ⚖️💉 #PharmaTransparency #HealthJustice #DeadlyPrices
Anja Reul 📯"#MultiresistenteBakterien töten 10Tausende in Europa, weil #Antibiotika nicht wirken"
"Der #Ukraine-#Krieg facht die Besorgnis über die weltweite #Bakterienresistenz an"
#Deadlyprices
Antibiotic defences: Ukraine war reignites concerns over global bacteria resistance
https://www.investigate-europe.eu/posts/deadly-prices-antibiotic-defences-ukraine-war-reignites-concerns-global-bacteria-resistance
Antibiotic defences: Ukraine war reignites concerns over global bacteria resistance
Multi-resistant bacteria kill tens of thousands in Europe as the antibiotics don't work. New types are less profitable to develop, so it is not done. Faced with the third biggest threat to public health in Europe, the EU is proposing billions in subsidies to tempt the pharma industry into action.
#InvestigateEU:
#Pharmaindustrie spendet 110 Mio € an #Patient*innen-#Interessenvertretungen in #Europa.
Die #Unabhängigkeit dieser #Gemeinnutzlobbys ist damit bedroht.
#Health / #Deadlyprices
#Drugfirms finance Europe’s patient groups with multi-million #donations
https://www.investigate-europe.eu/posts/deadly-prices-drug-firms-pharmaceuticals-finance-europe-patient-groups-charities-110-million-euros
Drug firms finance Europe’s patient groups with multi-million donations
Pharmaceutical industry pours €110 million into advocacy organisations across the continent, Investigate Europe research reveals. Critics argue that funding threatens “independence” of the sector, claims that are rejected by groups.
Kurz nach Veröffentlichung der Recherche über die #EMA hat die #EUKommission die erneute Prüfung eines Medikaments angeordnet, bei dem die Ablehnung der #Zulassung umstritten war.
#DeadlyPrices:
European Commission rejects cancer drug removal over ‘impartiality’ concerns
https://www.investigate-europe.eu/posts/deadly-prices-european-commission-rejects-cancer-drug-removal-over-impartiality-concerns
Deadly prices: European Commission rejects cancer drug removal over ‘impartiality’ concerns
Days after our investigation into the European Medicines Agency, the European Commission ordered the re-examination of a drug which the medicines regulator had controversially rejected for authorisation
5/ #DeadlyPrices enstehen durch #ProfitLobbyismus der #PharmaIndustrie.
Das geheime #Preissystem für #Arzneimittel in #Europa mit #intransparenten Absprachen macht lebenswichtige Medikamente für Mio. #Patient*innen unerreichbar.
Deadly prices
https://www.investigate-europe.eu/themes/investigations/deadly-prices-europe-big-pharma-medicines
4/ #Pharmariesen haben > 1.300 #Tochtergesellschaften in #Niedrigsteuergebieten.
#Patient*innen müssen wg. hoher #Arzneimittelpreise gefährl. lang warten
#DeadlyPrices
#Pharmafirms stash profits in Europe's #taxhavens as patients struggle with #drugprices
https://www.investigate-europe.eu/posts/deadly-prices-pharma-firms-stash-profits-in-europes-tax-havens-as-patients-struggle-with-drug-prices
Pharma firms stash profits in Europe's tax havens as patients struggle with drug prices
Investigate Europe finds 15 of the world’s biggest drugmakers operate more than 1,300 subsidiaries in tax havens, as they amassed over €580 billion in global profits over the past five years. Meanwhile, patients face life-threatening delays for medicines due to high drug prices.
3/ Die #EMA unterliegt "#Interessenkonflikten aufgrund berufl. & finanz. #Verbindungen zur #Industrie".
#Medikamente werden teilw. trotz #Risiken im Schnellverfahren entwickelt.
#DeadlyPrices
#BigPharma influence hangs over Europe’s medicines regulator
https://www.investigate-europe.eu/posts/deadly-prices-big-pharma-influence-hangs-over-europes-medicines-regulator
Big pharma influence hangs over Europe’s medicines regulator
The European Medicines Agency is beset by several conflicts of interest with concerns over professional and financial ties to industry. It is also facing growing criticism for fast-tracking drugs that could pose serious risks to patients.
2/ "#MultiresistenteKeime töten Zehntausende in Europa, weil #Antibiotika nicht wirken.
#Pharmaindustrie handelt aus #Rentabilität|sgründen nicht oder zu zögerlich.
#DeadlyPrices
#Antibioticdefences:
Ukraine war reignites concerns over global #bacteriaresistance
https://www.investigate-europe.eu/posts/deadly-prices-antibiotic-defences-ukraine-war-reignites-concerns-global-bacteria-resistance
Antibiotic defences: Ukraine war reignites concerns over global bacteria resistance
Multi-resistant bacteria kill tens of thousands in Europe as the antibiotics don't work. New types are less profitable to develop, so it is not done. Faced with the third biggest threat to public health in Europe, the EU is proposing billions in subsidies to tempt the pharma industry into action.
1/ #DeadlyPrices
Stell dir vor, ein geliebter Mensch leidet & stirbt vielleicht, obwohl es wirksame #Medikamente zur #Linderung oder #Heilung gibt oder geben könnte.
Das erleben unzählige Menschen, weil die #PharmaLobby Preise aufruft, die #Krankenkassen teilweise nicht zahlen können.
Dazu 4 Artikel von #Investigate Europe⬇️